Khaled Musallam/LinkedIn
Sep 28, 2025, 08:41
Khaled Musallam Explores Molecular Understanding of β-Thalassemia at The 2nd Abu Dhabi Hematology Annual Review
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared on LinkedIn:
”Great program and talks during the 2nd Abu Dhabi Hematology Annual Review.
Thanks Dr Kayane Mheidly and Sheikh Shakhbout Medical City – SSMC for giving the stage to thalassemia.”

Stay updated with Hemostasis Today.
-
Jul 17, 2026, 18:20Sarah Jones: Bringing Vessel-on-a-Chip Research to ISTH 2026
-
Jul 17, 2026, 18:06Virginia Barras Sánchez: United by a Commitment to Hemophilia at ISTH 2026
-
Jul 17, 2026, 17:53Micah Grey: Shaping the Future of Hematology at ISTH 2026
-
Jul 17, 2026, 17:32Vasiliki Danilatou: Advancing β-Thalassemia Research at ISTH 2026
-
Jul 17, 2026, 14:4010 Key Topics Presented at EHA2026 Congress
-
Jul 17, 2026, 13:47Clare Martin: Official Launch of the International Working Group for TTP
-
Jul 17, 2026, 13:36Ludwig Traby: Returning to ISTH with a New Perspective on SIC
-
Jul 17, 2026, 13:16Alex Santos: The Best Part Was Never on the Slides
-
Jul 17, 2026, 13:03Gael Morrow: Supporting Career Development at ISTH